Adagio Medical Holdings (ADGM) Net Income towards Common Stockholders (2023 - 2026)

Adagio Medical Holdings has disclosed Net Income towards Common Stockholders across 4 years of filings, most recently posting -$5.7 million for Q2 2026.

• In Q2 2026, Net Income towards Common Stockholders fell 6.22% year-over-year to -$5.7 million; the TTM figure through Jun 2026 stood at -$22.5 million (up 11.05% YoY), while the FY2025 annual figure was -$25.1 million, up 53.34% from the prior year.
• Net Income towards Common Stockholders came in at -$5.7 million for Q2 2026 at Adagio Medical Holdings, up from -$5.9 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of -$4.6 million in Q4 2025 to a low of -$9.6 million in Q1 2024.
• Average Net Income towards Common Stockholders over 4 years is -$6.6 million, with a median of -$5.9 million recorded in 2023.
• Year-over-year, Net Income towards Common Stockholders soared 50.92% in 2024 and sank 36.15% in 2025.
• Over 4 years, Net Income towards Common Stockholders stood at -$5.9 million in 2023, then gained by 20.56% to -$4.7 million in 2024, then climbed by 1.77% to -$4.6 million in 2025, then dropped by 22.9% to -$5.7 million in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$5.7 million in Q2 2026, -$5.9 million in Q1 2026, and -$4.6 million in Q4 2025.